IQVIA MRES (Medical Research Extraction Scheme)

The Clinical Research Network West Midlands is pleased to announce that we are working with IQVIA to support practices to sign up to the Medical Research Extraction Scheme.

The report following this survey, carried out earlier this year by the Central Patient and Public Involvement & Engagement Team, is now available. CRN WM was one of three Local Clinical Research Networks (LCRNs) which developed and piloted the survey and returned the largest number of responses (318 of 597).

It is estimated that 1 in 4 people in England will experience a mental health problem in any given year. Mental health problems are one of the main causes of the burden of disease worldwide (estimated at £16 trillion). In the UK they are responsible for the largest burden of disease (28%) at £70-100 billion each year, compared to 16% each for cancer and heart disease (www.mentalhealth.org.uk). It is clear mental health research is needed to improve the effectiveness of treatments for people experiencing mental health difficulties, as well as for finding ways of preventing poor mental health.

As part of our strategy to increase research awareness amongst the public, the NIHR Clinical Research Network West Midlands now has a social media presence.

We are asking all of our colleagues, if possible, to please follow and like us on Twitter and Facebook. The addresses are:

Twitter: @CRN_WMid

Facebook: www.facebook.com/CRNWMid 

The Research Incentive Scheme (RIS) was established in 2010 and, over the years, has proved a very popular initiative.

Remuneration is on a sliding scale, depending on the level of involvement and number of studies a practice has recruited to.

Electronic health databases have been used widely in health research for years, consisting of data derived from routinely collected health records generated by daily clinical practice. Clinical Practice Research Datalink (CPRD) is one of the largest databases of longitudinal medical records from primary care in the world.  

Working with Pharmaceutical Companies to Deliver Industry Interventional Clinical Trials